Unknown

Dataset Information

0

KCP10043F Represses the Proliferation of Human Non-Small Cell Lung Cancer Cells by Caspase-Mediated Apoptosis via STAT3 Inactivation.


ABSTRACT: We previously reported that 4-(4-fluorobenzylcarbamoylmethyl)-3-(4-cyclohexylphenyl)-2-[3-(N,N-dimethylureido)-N'-methylpropylamino]-3,4-dihydroquinazoline (KCP10043F) can induce G1-phase arrest and synergistic cell death in combination with etoposide in lung cancer cells. Here, we investigated the underlying mechanism by which KCP10043F induces cell death in non-small cell lung cancer (NSCLC). Propidium iodide (PI) and annexin V staining revealed that KCP10043F-induced cytotoxicity was caused by apoptosis. KCP10043F induced a series of intracellular events: (1) downregulation of Bcl-2 and Bcl-xL and upregulation of Bax and cleaved Bid; (2) loss of mitochondrial membrane potential; (3) increase of cytochrome c release; (4) cleavage of procaspase-8, procaspase-9, procaspase-3, and poly (ADP-ribose) polymerase (PARP). In addition, KCP10043F exhibited potent inhibitory effects on constitutive or interleukin-6 (IL-6)-induced signal transducer and activator of transcription (STAT3) phosphorylation and STAT3-regulated genes including survivin, Mcl-1, and cyclin D1. Furthermore, STAT3 overexpression attenuated KCP10043F-induced apoptosis and the cleavage of caspase-9, caspase-3, and PARP. Docking analysis disclosed that KCP10043F could bind to a pocket in the SH2 domain of STAT3 and prevent STAT3 phosphorylation. The oral administration of KCP10043F decreased tumor growth in an A549 xenograft mouse model, as associated with the reduced phosphorylated STAT3, survivin, Mcl-1, and Bcl-2 expression and increased TUNEL staining and PARP cleavage in tumor tissues. Collectively, our data suggest that KCP10043F suppresses NSCLC cell growth through apoptosis induction via STAT3 inactivation.

SUBMITTER: Lee JH 

PROVIDER: S-EPMC7141374 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

KCP10043F Represses the Proliferation of Human Non-Small Cell Lung Cancer Cells by Caspase-Mediated Apoptosis via STAT3 Inactivation.

Lee Jeong-Hun JH   Lee Hwi-Ho HH   Ryu Ki Deok KD   Kim Misong M   Ko Dohyeong D   Chung Kyung-Sook KS   Hassan Ahmed H E AHE   Lee Seung Hyeun SH   Lee Jae Yeol JY   Lee Kyung-Tae KT  

Journal of clinical medicine 20200305 3


We previously reported that 4-(4-fluorobenzylcarbamoylmethyl)-3-(4-cyclohexylphenyl)-2-[3-(<i>N,N</i>-dimethylureido)-<i>N'</i>-methylpropylamino]-3,4-dihydroquinazoline (KCP10043F) can induce G<sub>1</sub>-phase arrest and synergistic cell death in combination with etoposide in lung cancer cells. Here, we investigated the underlying mechanism by which KCP10043F induces cell death in non-small cell lung cancer (NSCLC). Propidium iodide (PI) and annexin V staining revealed that KCP10043F-induced  ...[more]

Similar Datasets

| S-EPMC8184448 | biostudies-literature
| S-EPMC8655134 | biostudies-literature
| S-EPMC9308799 | biostudies-literature
2024-01-26 | PXD046139 | Pride
| S-EPMC6986254 | biostudies-literature
| S-EPMC5731931 | biostudies-literature
| S-EPMC7020344 | biostudies-literature
| S-EPMC6652730 | biostudies-literature
| S-EPMC6176365 | biostudies-other
| S-EPMC7853870 | biostudies-literature